Business
Immunic to Participate in Scientific and Investor Conferences in February
NEW YORK, Jan. 25, 2023 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral
About this update from Immunic, Inc.
[{"type":"text","content":"NEW YORK, Jan. 25, 2023 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced participation in the following scientific and investor conferences in February:\nFebruary 1-2: 31st Pharmacovigilance 2023. Darius-Jean Namdjou, Ph.D., Head of Regulatory Affairs & Pharmacovigilance at Immunic, will participate as a panelist in a roundtable discussion entitled, \"Regulatory - EU and UK Regulations & Guidelines in Pharmacovigilance\" at this conference in London on Thursday, February 2, 2023, at 4:00 pm GMT.February 9: Immunic's Celiac Disease R&D Webcast. Immunic's management will be joined by renowned key opinion leaders to discuss today's treatment options and the unmet medical need for celiac disease, in a webcast on February 9, 2023, at 11:00 am ET. Featured key opinion leaders will be:Joseph A. Murray, M.D., Professor of Medicine, Director, Celiac Disease Research, John and Shirley Berry Professor of Gastrointestinal Sciences, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, MNMichael Schumann, M.D., Attending Physician in Internal Medicine and Gastroenterology, Department of Gastroenterology, Infectious Diseases and Rheumatology, Campus Benjamin Franklin, Charité – Universitätsmedizin BerlinThe celiac disease R&D webcast will be held virtually via Zoom. To participate, please register in advance at: https://imux.zoom.us/webinar/register/WN_wI-01YeJSbe4XRTFO1PLQw. Registrants will receive a confirmation email containing a link for online participation or a telephone number for dial in access. An archived replay of the webcast will be available on the \"Events and Presentations\" section of Immunic's website at: https://ir.imux.com/events-and-presentations.\nFebruary 13-16: SVB Securities Global Biopharma Conference. Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic, will present a company overview at this virtual conference on Thursday, February 16, 2023, at 1:40 pm ET. A live webcast of the presentation will be available on the \"Events and Presentations\" section of Immunic's website at: ir.imux.com/events-and-presentations. An archived replay will be available on the company's websi...